Background
Fletikumab (NNC0109-0012) is a monoclonal antibody targeting to IL-20. Fletikumab can be used for inflammation research, such as rheumatoid arthritis.• Immune responses to injury and their links to eye disease., PMID:34051364• Regulation and functions of the IL-10 family of cytokines in inflammation and disease., PMID:21166540• IL-20 controls resolution of experimental colitis by regulating epithelial IFN/STAT2 signalling., PMID:37884352• Dnmt3a-mutated clonal hematopoiesis promotes osteoporosis., PMID:34698806• Interleukin-20 is involved in dry eye disease and is a potential therapeutic target., PMID:35681232• The IL-20 Cytokine Family in Rheumatoid Arthritis and Spondyloarthritis., PMID:30319661• The Interleukin-20 Cytokine Family in Liver Disease., PMID:29892294• Interleukin-20., PMID:15120648• Interleukin 24: Signal Transduction Pathways., PMID:37444474• Interleukin-19 as an Immunoregulatory Cytokine., PMID:32329704